Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Steriscience
FDA Approves FOCINVEZ — Steriscience Specialties Private Limited

# FDA Approves Steriscience Specialties' FOCINVEZ, Expanding IV Antiemetic Options in Competitive Market Steriscience Specialties Private Limited rec...

SPECGX
FDA Approves Unknown Drug — SPECGX LLC

FDA has approved a generic drug from SPECGX LLC, representing an immediate entry for a branded product with significant commercial potential. The appr...

Ipsen
FDA Approves SOHONOS — Ipsen Biopharmaceuticals, Inc.

Ipsen Biopharmaceuticals, Inc. announced FDA approval of palovarotene soft capsules (Sohonos), intended for pediatric patients with amenable ichthyose...

Ajanta
FDA Approves TOPIRAMATE — Ajanta Pharma USA Inc.

On August 15, 2023, Ajanta Pharma USA Inc. received FDA approval for its generic form of topiramate, a seizure medication that generated more than $1 ...

Janssen
FDA Approves TALVEY — Janssen Biotech, Inc.

(Janssen) announced Wednesday the FDA approval of Talvey (talquetamab), a novel antibody directed against both GPRC5D and BCMA, which targets multiple...

TORRENT
FDA Approves Unknown Drug — TORRENT

# FDA Approves Torrent Pharmaceutical's ANDA Application Torrent Pharmaceuticals received FDA approval for ANDA213405 on August 3, 2023, expanding it...

Mylan
FDA Approves SAXAGLIPTIN AND METFORMIN — Mylan Pharmaceuticals Inc.

Mylan Pharmaceuticals Inc. announced on Friday the U.S. approval of its ANDA for saxagliptin and metformin, initiating a new competitive entry into th...

WG
FDA Approves MEROPENEM — WG Critical Care, LLC

WG Critical Care, LLC announced the FDA approval of its Meropenem IV injection (NDA215212) on July 26, 2023, positioning the manufacturer to strengthe...

Daiichi
FDA Approves VANFLYTA — Daiichi Sankyo Inc.

# FDA Approves Daiichi Sankyo's VANFLYTA (quizartinib) for FLT3-Mutated Acute Myeloid Leukemia Daiichi Sankyo Inc. announced FDA approval of VANFLYTA...

Zydus
FDA Approves OXCARBAZEPINE — Zydus Lifesciences Limited

# FDA Approves Generic Oxcarbazepine Oral Formulation by Zydus Lifesciences Zydus Lifesciences Limited has received FDA approval for a generic versio...

Pfizer
FDA Approves NGENLA — Pfizer Laboratories Div Pfizer Inc

# FDA Approves Pfizer's NGENLA (somatrogon-ghla) for Growth Hormone Deficiency Pfizer has received FDA approval for NGENLA (somatrogon-ghla), a long-...

Pfizer
FDA Approves LITFULO — Pfizer Laboratories Div Pfizer Inc

Pfizer has announced the FDA approval of the oral drug Ritlecitinib Tosylate (LITFULO) for the treatment of alopecia areata, marking the pharma giant'...

Genentech,
FDA Approves COLUMVI — Genentech, Inc.

Genentech, Inc. received FDA approval in June 2023 for its intravenous antibody drug Glufitamab under the brand name COLUMVI, a significant milestone ...

Camber
FDA Approves EPLERENONE — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals has received FDA approval for its Eplerenone oral tablets, serving as a new generic entry in the market for this heart failure ...

BPI
FDA Approves Unknown Drug — BPI LABS

BPI LABS has secured a key regulatory milestone with today’s FDA approval of ANDA 214283, signaling the company’s intent to enter a substantial and ac...

Pfizer
FDA Approves PAXLOVID — Pfizer Laboratories Div Pfizer Inc

# FDA Approves Pfizer's Paxlovid as Antiviral Treatment Pfizer announced FDA approval of Paxlovid (nirmatrelvir and ritonavir) on May 25, 2023, solid...

NorthStar
FDA Approves HALOPERIDOL DECANOATE — NorthStar RxLLC

# FDA Approves NorthStar RxLLC's Haloperidol Decanoate for Intramuscular Administration The FDA has approved NorthStar RxLLC's haloperidol decanoate ...

Aurohealth
FDA Approves FEXOFENADINE HYDROCHLORIDE — Aurohealth LLC

**Aurohealth LLC received FDA approval on May 23 for its ANDA 213466 for FEXOFENADINE HYDROCHLORIDE Oral, introducing an additional generic alternativ...

Genmab
FDA Approves EPKINLY — Genmab US, Inc.

Genmab US, Inc. received FDA approval on May 19, 2023, for EPKINLY (epcoritamab-bysp), a bispecific CD3xCD20 antibody administered subcutaneously, whi...

Camber
FDA Approves LENALIDOMIDE — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals, Inc. announced the FDA’s approval of its ANDA for oral Lenalidomide, granting the company a license to market a generic versio...